Posted inOpinion, Opinion Columns

Opinion: Colorado needs a Prescription Drug Affordability Board to protect the public interest

As someone living with multiple sclerosis, I have seen first hand the cost of MS disease modifying therapies (DMTs) rise, making these essential medications unattainable for some patients.   Drug prices for individuals with MS quadrupled between 2006 and 2016 and continue to rise. MS DMT costs have accelerated at rates far beyond inflation and considerably […]